Table 3.
A. Stimulated C-peptides at 1-month post diagnosis | |||
---|---|---|---|
R2 | t-ratio | P | |
Individual parameters | |||
C4A CNV | 0.215 | 2.87 | 0.0075 |
C4A cone. | 0.209 | 2.82 | 0.0085 |
HLA-DR3 * | 0.138 | −2.20 | 0.036 |
BMI | 0.310 | 3.67 | 0.0009 |
Z-BMI | 0.184 | 2.61 | 0.014 |
age of onset | 0.06 | 1.43 | 0.162 |
Regression Model 1: C4A CNV and BMI | |||
model | 0.405 | 9.85* | 0.0005 |
C4A CNV | 2.15 | 0.040 | |
BMI | 3.04 | 0.005 | |
Regression Model 2: C4A protein cone, and BMI | |||
model | 0.423 | 10.6¶ | 0.0003 |
C4A cone. | 2.39 | 0.024 | |
BMI | 3.28 | 0.0027 | |
Regression Model 3: HLA-DR3 and BMI | |||
model | 0.405 | 9.87¶ | 0.0005 |
HLA-DR3 | −2.16 | 0.040 | |
BMI | 3.61 | 0.0012 |
B. End of partial disease remission at 9-month | |||
---|---|---|---|
R2 | χ 2 | P | |
Individual parameters | |||
C4B CNV | 0.162 | 5.74 | 0.0166 |
C4B cone. | 0.355 | 12.6 | 0.0004 |
DR3/DR4 * | 0.161 | 5.71 | 0.0169 |
Regression Model 4: C4B-CNV and DR3/DR4 | |||
model | 0.355 | 12.6 | 0.0018 |
C4B-CHV | 6.88 | 0.0087 | |
DR3/DR4 * | 6.85 | 0.0089 | |
Regression Model 4: C4B cone. andDR3/DR4 | |||
model | 0.471 | 16.8 | 0.0002 |
C4B cone. | 11.0 | 0.0009 | |
DR3/DR4 * | 4.09 | 0.043 |
inverse association
F-ratio value is presented.